Puma Biotechnology Inc (PBYI) - Financial and Strategic SWOT Analysis Review

July 2021 | 51 pages | ID: P28DA47C441EN
GlobalData

Abstracts

Puma Biotechnology Inc (PBYI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Puma Biotechnology Inc (Puma) is a biopharmaceutical company that develops novel therapeutics for the treatment of cancer. The company develops and commercializes drug candidates, namely, PB272 (neratinib, oral), PB272 (neratinib, intravenous) and PB357. Its pipeline portfolio also encompasses investigational candidates for various indications such as adjuvant breast cancer, gastric cancer, metastatic breast cancer and HER2-positive breast cancer and other cancers. Puma in-licenses its drug candidates and advances its development through clinical testing and for commercial use. Puma is headquartered in Los Angeles, California, the US.

Puma Biotechnology Inc Key Recent Developments

May 06,2021: Puma Biotechnology Reports First Quarter 2021 Financial Results
Mar 04,2021: Puma Biotechnology to Present at the Barclays Global Healthcare Conference
Mar 02,2021: Puma Biotechnology to Present at the H.C. Wainwright Global Life Sciences Conference
Feb 11,2021: Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2020 Financial Results
Jan 19,2021: Puma Biotechnology to Present at the B. Riley Oncology Investor Conference

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Puma Biotechnology Inc - Key Facts
Puma Biotechnology Inc - Key Employees
Puma Biotechnology Inc - Key Employee Biographies
Puma Biotechnology Inc - Major Products and Services
Puma Biotechnology Inc - History
Puma Biotechnology Inc - Company Statement
Puma Biotechnology Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Puma Biotechnology Inc - Business Description
Business Segment: License Revenue
Performance
Business Segment: Product Revenue
Performance
Business Segment: Royalty Revenue
Performance
R&D Overview
Puma Biotechnology Inc - Corporate Strategy
Puma Biotechnology Inc - SWOT Analysis
SWOT Analysis - Overview
Puma Biotechnology Inc - Strengths
Puma Biotechnology Inc - Weaknesses
Puma Biotechnology Inc - Opportunities
Puma Biotechnology Inc - Threats
Puma Biotechnology Inc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Puma Biotechnology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Puma Biotechnology Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Puma Biotechnology Inc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

May 06, 2021: Puma Biotechnology Reports First Quarter 2021 Financial Results
Mar 04, 2021: Puma Biotechnology to Present at the Barclays Global Healthcare Conference
Mar 02, 2021: Puma Biotechnology to Present at the H.C. Wainwright Global Life Sciences Conference
Feb 11, 2021: Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2020 Financial Results
Jan 19, 2021: Puma Biotechnology to Present at the B. Riley Oncology Investor Conference
Jan 05, 2021: Puma Biotechnology to Present at the J.P. Morgan Healthcare Conference
Nov 05, 2020: Puma Biotechnology reports third quarter 2020 financial results
Aug 06, 2020: Puma Biotechnology reports second quarter 2020 financial results
Jul 08, 2020: Puma Biotechnology: Departure of directors or principal officers; election of directors; appointment of principal officers.
May 07, 2020: Puma Biotechnology reports first quarter 2020 financial results

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Puma Biotechnology Inc, Key Facts
Puma Biotechnology Inc, Key Employees
Puma Biotechnology Inc, Key Employee Biographies
Puma Biotechnology Inc, Major Products and Services
Puma Biotechnology Inc, History
Puma Biotechnology Inc, Subsidiaries
Puma Biotechnology Inc, Key Competitors
Puma Biotechnology Inc, Ratios based on current share price
Puma Biotechnology Inc, Annual Ratios
Puma Biotechnology Inc, Annual Ratios (Cont...1)
Puma Biotechnology Inc, Interim Ratios
Puma Biotechnology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Puma Biotechnology Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Puma Biotechnology Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Puma Biotechnology Inc, Performance Chart (2016 - 2020)
Puma Biotechnology Inc, Ratio Charts
Puma Biotechnology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Puma Biotechnology Inc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021